STELARA

• tagApproval270 co-mentions · 91 sources
• drugustekinumab223 co-mentions · 91 sources
• tagOrthopedics60 co-mentions · 30 sources
• companyJanssen Biotech Inc28 co-mentions · 14 sources
• drugPYZCHIVA26 co-mentions · 13 sources
• drugOTULFI18 co-mentions · 9 sources
• companySamsung Bioepis Co Ltd13 co-mentions · 13 sources
• drugWEZLANA12 co-mentions · 6 sources

Trials studying STELARA

• phase3A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasisactive not recruitingn=752
• phase3A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Diseaseactive not recruitingn=1,409
• phase3Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)recruitingn=3,040
• phase3A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasiscompletedn=567
• phase3A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritisactive not recruitingn=50
• —A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitisrecruitingn=1,056
• phase3A Long-term Extension Study of Ustekinumab in Pediatric Participantsactive not recruitingn=159
• phase3Loss of RESponse to Ustekinumab Treated by Dose Escalationcompletedn=108